Explained: The Covid-19 vaccines India is making, testing and supplying - Includes Biological E in collaboration with #Baylor College of Medicine

 

Explained: The Covid-19 vaccines India is making, testing and supplying

https://indianexpress.com/article/explained/the-covid-19-vaccines-india-is-making-testing-and-supplying-7234851/ @IndianExpress

BECOV2A, BECOV2B, BECOV2C, BECOV2D

Company: Biological E in collaboration with #Baylor College of Medicine
Platform: Recombinant protein vaccine containing SARS-CoV-2 receptor binding domain
Number of doses: 2
Capacity: Around 1 billion doses a year
Efficacy: Not available yet (phase 3 trial yet to begin)
Status: Phase 1 and 2 human trials in India completed. Depending on findings, expected to be published soon, the company will approach India’s drug regulator for permission to conduct phase 3 trials.

#unido #SARSCoV2